TW

Toni Weinschenk

IG Immatics Biotechnologies Gmbh: 595 patents #1 of 99Top 2%
IG Inmatics Biotechnologies Gmbh: 6 patents #1 of 8Top 15%
MA Morphosys Ag: 1 patents #63 of 111Top 60%
📍 Rötteln, DE: #1 of 115 inventorsTop 1%
Overall (All Time): #249 of 4,157,543Top 1%
606
Patents All Time

Issued Patents All Time

Showing 226–250 of 606 patents

Patent #TitleCo-InventorsDate
11111280 Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers Andrea Mahr, Valentina Goldfinger, Oliver Schoor, Jens Fritsche, Harpreet Singh 2021-09-07
11103535 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Daniel Johannes KOWALEWSKI +1 more 2021-08-31
11083784 Peptides and combination of peptides for use in immunotherapy against CLL and other cancers Andrea Mahr, Anita Wiebe, Oliver Schoor, Jens Fritsche, Harpreet Singh 2021-08-10
11077171 Immunotherapy against several tumors including gastrointestinal and gastric cancer Jens Fritsche, Steffen Walter, Peter Lewandrowski, Harpreet Singh 2021-08-03
11077142 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Daniel Johannes KOWALEWSKI +1 more 2021-08-03
11071773 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Andrea Mahr, Oliver Schoor, Jens Fritsche, Harpreet Singh, Claudia WAGNER +2 more 2021-07-27
11065316 Peptides and T cells for use in immunother[[r]]apeutic treatment of various cancers Andrea Mahr, Oliver Schoor, Jens Fritsche, Harpreet Singh 2021-07-20
11065315 Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers Andrea Mahr, Oliver Schoor, Jens Fritsche, Harpreet Singh, Phillip Mueller +2 more 2021-07-20
11065314 Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers Andrea Mahr, Helen Hoerzer, Oliver Schoor, Jens Fritsche, Harpreet Singh 2021-07-20
11065279 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Daniel Johannes KOWALEWSKI +1 more 2021-07-20
11058755 A*03 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Linus Backert, Heiko SCHUSTER, Daniel Johannes KOWALEWSKI, Oliver Schoor +2 more 2021-07-13
11058754 Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers Andrea Mahr, Oliver Schoor, Jens Fritsche, Harpreet Singh, Phillip Mueller +2 more 2021-07-13
11058727 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Daniel Johannes KOWALEWSKI +1 more 2021-07-13
11058726 Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Andrea Mahr, Anita Wiebe, Colette Song, Oliver Schoor, Jens Fritsche +1 more 2021-07-13
11052114 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Daniel Johannes KOWALEWSKI +1 more 2021-07-06
11052113 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Daniel Johannes KOWALEWSKI +1 more 2021-07-06
11040069 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Daniel Johannes KOWALEWSKI +1 more 2021-06-22
11033585 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Daniel Johannes KOWALEWSKI +1 more 2021-06-15
11033583 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Daniel Johannes KOWALEWSKI +1 more 2021-06-15
11027002 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Andrea Mahr, Oliver Schoor, Jens Fritsche, Harpreet Singh, Claudia WAGNER +2 more 2021-06-08
11026977 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Daniel Johannes KOWALEWSKI +1 more 2021-06-08
11020434 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Daniel Johannes KOWALEWSKI +1 more 2021-06-01
11020433 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Daniel Johannes KOWALEWSKI +1 more 2021-06-01
11014972 B*44 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Heiko SCHUSTER, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche +1 more 2021-05-25
11013769 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Daniel Johannes KOWALEWSKI +1 more 2021-05-25